| 1 |
Durvalumab Or Placebo Plus Gemcitabine And Cisplatin In Participants With Advanced Biliary Tract Cancer (Topaz 1): Updated Overall Survival From A Randomised Phase 3 Study
DOI: 10.1016/S2468-1253(24)00095-5
|
WoS: WOS:001267649100001
Scopus: SCOPUS_ID:85195637201
|
Lancet Gastroenterology & Hepatology
|
WOS
Scopus
|
Article
|
-
OH, DO-YOUN
-
HE, AIWU RUTH
-
BOUATTOUR, MOHAMED
-
OKUSAKA, TAKUJI
-
QIN, SHUKUI
-
CHEN, LI-TZONG
-
KITANO, MASAYUKI
-
LEE, CHOONG-KUN
-
KIM, JIN WON
-
CHEN, MING -HUANG
-
SUKSOMBOONCHAROEN, THATTHAN
-
IKEDA, MASAFUMI
-
LEE, MYUNG AH
-
CHEN, JEN-SHI
-
POTEMSKI, PIOTR
-
BURRIS, HOWARD A.
-
OSTWAL, VIKAS
-
TANASANVIMON, SUEBPONG
-
MORIZANE, CHIGUSA
-
ZAUCHA, RENATA E.
-
MCNAMARA, MAIREAD G.
-
AVALLONE, ANTONIO
-
CUNDOM, JUAN E.
-
BREDER, VALERIY
-
TAN, BENJAMIN
-
SHIMIZU, SATOSHI
-
TOUGERON, DAVID
-
EVESQUE, LUDOVIC
-
PETROVA, MILA
-
ZHEN, DAVID B.
-
GILLMORE, ROOPINDER
-
GUPTA, VINEET GOVINDA
-
DAYYANI, FARSHID
-
PARK, JOON OH
-
BUCHSCHACHER JR, GARY L.
-
REY, FELIPE
-
KIM, HYOSUNG
-
WANG, JULIE
-
MORGAN, CLAIRE
-
ROKUTANDA, NANA
-
ZOTKIEWICZ, MAGDALENA
-
VOGEL, ARNDT
-
VALLE, JUAN W.
-
OH, DO YOUN
-
CHEN, LI TZONG
-
LEE, CHOONG KUN
-
CHEN, MING HUANG
-
CHEN, JEN SHI
-
BUCHSCHACHER, GARY L.
-
46 Autores más
-
Esconder
|
2024
|